The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of the OX40 agonist BGB-A445, with or without tislelizumab, an anti-PD-1 monoclonal antibody, in patients with advanced NSCLC, HNSCC, or NPC.
 
Min Hee Hong
Stock and Other Ownership Interests - GI biome; GI cell
Honoraria - AstraZeneca; BeiGene; Merck; Roche
Consulting or Advisory Role - AstraZeneca; BeiGene; Daiichi Sankyo/Astra Zeneca; Merck; Roche; Yuhan
Research Funding - Yuhan
 
Byoung Chul Cho
Employment - Yonsei University Health System
Leadership - J INTS BIO
Stock and Other Ownership Interests - Bridgebio; Cyrus therapeutics; Gencurix; Interpark Bio; J INTS BIO; Kanaph Therapeutics; Theravance
Consulting or Advisory Role - Amgen; AnHeart Therapeutics; ArriVent Biopharma; AstraZeneca; BeiGene; BMS; Boehringer Ingelheim; Bridgebio; CJ bioscience; Cyrus therapeutics; Cyrus therapeutics; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Guardant Health; Harpoon Therapeutics; J INTS Bio; Janssen; Kanaph Therapeutics; Lilly; MSD; Novartis; Ono Pharmaceutical; Pfizer; Regeneron; Roche; Sanofi; Seagen; Takeda; Therapex Co., Ltd; Yuhan
Research Funding - AstraZeneca; Champions Oncology; CJ bioscience; Cyrus Therapeutics; Dong-A ST; GI Innovation; ImmuneOncia; J Ints Bio; Janssen; MSD; Therapex; Vertical Bio AG; Yuhan
Patents, Royalties, Other Intellectual Property - Champions Oncology; Crown Bioscience; Imagen; PearlRiver Bio GmbH
Other Relationship - DAAN Biotherapeutics
 
Sanjeev Deva
Travel, Accommodations, Expenses - Roche
 
Fang Ma
No Relationships to Disclose
 
Jianhua Shi
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Pei Jye Voon
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Johnson & Johnson/Janssen; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer
Speakers' Bureau - Amgen; AstraZeneca; Johnson & Johnson/Janssen; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer
Research Funding - Amgen (Inst); AstraZeneca (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Johnson & Johnson/Janssen (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Revolution Medicines (Inst); ROCHE (Inst); Viracta Therapeutics (Inst)
 
David Dai Wee Lee
Honoraria - Abbvie; AstraZeneca/UK; Ipsen; Juniper Biologics; Merck; Pfizer; Roche; Takeda; Zuellig Pharma
Consulting or Advisory Role - Eisai; Ipsen; Pfizer; Zuellig Pharma
Research Funding - AstraZeneca/UK; BeiGene; Janssen; Sandoz
 
Shiangjiin Leaw
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Tahmina Rahman
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Hugh Giovinazzo
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Xin Chen
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Yan Dong
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Yifan Qin
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Youngjoo Lee
Consulting or Advisory Role - MSD; Roche; Yuhan